# Filing Detail

Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001178913-24-003893
Filing Date
2024-12-02
Accepted
2024-12-02 16:22:12
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | POS AM | zk2432420.htm | POS AM | 307809
2 | EXHIBIT 5.1 | exhibit_5-1.htm | EX-5.1 | 9935
3 | EXHIBIT 23.1 | exhibit_23-1.htm | EX-23.1 | 2236
4 | FILING FEES TABLE | exhibit_107.htm | EX-FILING FEES | 24630
5 |  | image00003.jpg | GRAPHIC | 4970
6 |  | image00004.jpg | GRAPHIC | 377003
7 |  | image00005.jpg | GRAPHIC | 175385
| Complete submission text file | 0001178913-24-003893.txt |  | 1113574

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255249 | Film No.: 241519352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)